Noncontrast-enhanced MRI-based noninvasive score for portal hypertension (CHESS1802): An international multicenter study
dc.authorid | 0000-0002-8909-2102 | en_US |
dc.authorscopusid | 56035868800 | en_US |
dc.authorwosid | AAU-7657-2020 | en_US |
dc.contributor.author | Liu, Yanna | |
dc.contributor.author | Tang, Tianyu | |
dc.contributor.author | Örmeci, Necati | |
dc.contributor.author | Huang, Yifei | |
dc.contributor.author | Wang, Jitao | |
dc.contributor.author | Li, Xiaoguo | |
dc.contributor.author | Li, Zhiwei | |
dc.contributor.author | An, Weimin | |
dc.contributor.author | Liu, Dengxiang | |
dc.contributor.author | Zhang, Chunqing | |
dc.contributor.author | Liu, Changchun | |
dc.contributor.author | Liu, Jinqiang | |
dc.contributor.author | Liu, Chuan | |
dc.contributor.author | Wang, Guangchuan | |
dc.contributor.author | Mosconi, Cristina | |
dc.contributor.author | Cappelli, Alberta | |
dc.contributor.author | Bruno, Antonio | |
dc.contributor.author | Akçalar, Seray | |
dc.contributor.author | Çelebioğlu, Emrecan | |
dc.contributor.author | Üstüner, Evren | |
dc.contributor.author | Bilgiç, Sadık | |
dc.contributor.author | Ellik, Zeynep | |
dc.contributor.author | Asiller, Özgün Ömer | |
dc.date.accessioned | 2021-12-22T11:32:14Z | |
dc.date.available | 2021-12-22T11:32:14Z | |
dc.date.issued | 2021 | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.description.abstract | Background and Aims This study aimed to determine the performance of the non-invasive score using noncontrast-enhanced MRI (CHESS-DIS score) for detecting portal hypertension in cirrhosis. Methods In this international multicenter, diagnostic study (ClinicalTrials.gov, NCT03766880), patients with cirrhosis who had hepatic venous pressure gradient (HVPG) measurement and noncontrast-enhanced MRI were prospectively recruited from four university hospitals in China (n=4) and Turkey (n=1) between December 2018 and April 2019. A cohort of patients was retrospectively recruited from a university hospital in Italy between March 2015 and November 2017. After segmentation of the liver on fat-suppressed T1-weighted MRI maps, CHESS-DIS score was calculated automatically by an in-house developed code based on the quantification of liver surface nodularity. Results A total of 149 patients were included, of which 124 were from four Chinese hospitals (training cohort) and 25 were from two international hospitals (validation cohort). A positive correlation between CHESS-DIS score and HVPG was found with the correlation coefficients of 0.36 (p<0.0001) and 0.55 (p<0.01) for the training and validation cohorts, respectively. The area under the receiver operating characteristic curve of CHESS-DIS score in detection of clinically significant portal hypertension (CSPH) was 0.81 and 0.9 in the training and validation cohorts, respectively. The intraclass correlation coefficients for assessing the inter- and intra-observer agreement were 0.846 and 0.841, respectively. Conclusions A non-invasive score using noncontrast-enhanced MRI was developed and proved to be significantly correlated with invasive HVPG. Besides, this score could be used to detect CSPH in patients with cirrhosis. | en_US |
dc.identifier.citation | Liu, Y., Tang, T., Örmeci, N., Huang, Y., Wang, J., Li, X., Li, Z., An, W., Liu, D., Zhang, C., Liu, C., Liu, J., Liu, C., Wang, G., Mosconi, C., Cappelli, A., Bruno, A., Akçalar, S., Çelebioğlu, E., … Qi, X. (2021). Noncontrast-enhanced MRI-based noninvasive score for portal hypertension (CHESS1802): An international multicenter study. Journal of Clinical and Translational Hepatology, 9(6), pp. 818-827. https://doi.org/10.14218/JCTH.2021.00177 | en_US |
dc.identifier.doi | 10.14218/JCTH.2021.00177 | en_US |
dc.identifier.endpage | 827 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | PMID: 34966645 | en_US |
dc.identifier.scopus | 2-s2.0-8512198782 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 818 | en_US |
dc.identifier.uri | https://doi.org/10.14218/JCTH.2021.00177 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/105 | |
dc.identifier.volume | 9 | en_US |
dc.identifier.wos | WOS:000702548100001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Örmeci, Necati | |
dc.language.iso | en | en_US |
dc.publisher | Xia & He Publishing Inc. | en_US |
dc.relation.ispartof | Journal of Clinical and Translational Hepatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Liver Cirrhosis | en_US |
dc.subject | Advanced Chronic Liver Disease | en_US |
dc.subject | Hepatic Venous Pressure Gradient | en_US |
dc.subject | Liver Surface Nodularity | en_US |
dc.subject | Imaging | en_US |
dc.title | Noncontrast-enhanced MRI-based noninvasive score for portal hypertension (CHESS1802): An international multicenter study | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |